Literature DB >> 6320012

Inverse relationship between neurotensin receptors and neurotensin-like immunoreactivity in cat striatum.

M Goedert, P W Mantyh, P C Emson, S P Hunt.   

Abstract

The adult corpus striatum in mammals is divided into distinct histochemical compartments. If the cat caudate nucleus is stained for acetylcholinesterase a number of macroscopically visible zones appear that have lower acetylcholinesterase activity than the surrounding tissue. These patches, called 'striosomes', correspond to regions of high [Met]-enkephalin-like immunoreactivity and dense opiate receptor binding and are related to the uneven distribution of striatal efferent neurones and cortical afferent terminations. One of the highest concentrations of neurotensin-like immunoreactivity is in the striatum and the immunoreactive material co-elutes with synthetic neurotensin on gel chromatography. Recently, we have found that neurotensin-like immunoreactivity in the cat caudate nucleus coincides with the striosomes. We have now localized neurotensin receptors in the cat caudate nucleus by autoradiography and found low density in the neurotensin-rich striosomes and a high density in the neurotensin-poor surrounding tissue.

Mesh:

Substances:

Year:  1984        PMID: 6320012     DOI: 10.1038/307543a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  3 in total

1.  Compartmental distribution of striatal cell bodies expressing [Met]enkephalin-like immunoreactivity.

Authors:  A M Graybiel; M F Chesselet
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

Review 2.  The dopamine hypothesis of schizophrenia: limbic interactions with serotonin and norepinephrine.

Authors:  J N Joyce
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

3.  Is oxytocin a trust hormone? Salivary oxytocin is associated with caution but not with general trust.

Authors:  Qiulu Shou; Junko Yamada; Kuniyuki Nishina; Masahiro Matsunaga; Toko Kiyonari; Haruto Takagishi
Journal:  PLoS One       Date:  2022-05-06       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.